HAIDER NURZAY: Open Payments
NPI 1992208789 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,734 in 80 payments from 17 companies in 2025. Trend: 2023 $3,897 · 2024 $1,476 · 2025 $1,734
Food & beverage: $1,734
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $435 |
| Ardelyx, Inc. | 18 | $297 |
| Amgen Inc. | 9 | $227 |
| ABBVIE INC. | 17 | $223 |
| Lilly USA, LLC | 6 | $135 |
| Exact Sciences Corporation | 4 | $84 |
| UCB, Inc. | 2 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| PFIZER INC. | 2 | $39 |
Products named: IBSRELA, AIRSUPRA, BREZTRI, UBRELVY, REPATHA, OTEZLA, Cologuard Collection Kit, MOUNJARO.
Industry payments across CA — which companies pay providers there.
